Innovative MedTech Companies Selected to Present to Collaborators, Strategic Partners, and Investors at AdvaMed 2007

Friday, August 24, 2007 General News
Email Print This Page Comment
Font : A-A+

WASHINGTON, Aug. 23 The inaugural AdvaMed 2007conference will include a Business Development Forum and company presentationprogram, offering medical device and technology companies from the UnitedStates and abroad a unique networking vehicle. The first 22 of 38 companieshave been selected to make company presentations to an audience of potentialinvestors, partners and business collaborators attending AdvaMed 2007. A totalof 38 companies will present at AdvaMed 2007.

Companies selected to participate in AdvaMed 2007 were chosen by acommittee comprised of leading business development and licensing executives,venture capitalists, and other industry experts. "The committee is thrilledwith the quality of applicants for the conference. The selected companies area combination of exciting technology innovators and commercial leaders in theMedTech industry," said Matt Rieke, M.D., Co-Chair of the AdvaMed 2007Business Development Committee and Partner at Quaker BioVentures. "We areproud of the first round of selection, and look forward to completing thecompany presentation selection process in early September. Applications arestill being accepted on a rolling basis through August."

Specific time slots and locations for each company presentation will beannounced in late September, along with the additional 16 presentingcompanies. Company presentations will be organized into a number ofcategories, including: Cardiovascular, Diagnostics, Imaging, MetabolicDisease/Obesity, Neurovascular, Ophthalmology, Orthopedics, Wound Care andadditional growth sectors. Presentations will be 14 minutes each in length andwill take place on Wednesday, October 3, 2007.

For more information about AdvaMed 2007, visit http://www.AdvaMed2007.com,call (202) 434-7213, or e-mail info@AdvaMed2007.com. Host sponsors for AdvaMed2007 include Covidien, Ernst & Young, Johnson & Johnson and Kaplan EduNeering.

About AdvaMed:

AdvaMed member companies produce the medical devices, diagnostic productsand health information systems that are transforming health care throughearlier disease detection, less invasive procedures and more effectivetreatments. Our members produce nearly 90 percent of the health caretechnology purchased annually in the United States and more than 50 percentpurchased annually around the world. AdvaMed members range from the largest tothe smallest medical technology innovators and companies. For moreinformation, visit http://www.advamed.org.

About AdvaMed 2007:

AdvaMed 2007 is the premier medical technology conference and exhibitionfor business leaders, policymakers, investors, news media, patient advocates,and industry stakeholders from around the world. This year's conference offersa variety of workshops and panel discussions on subjects such as Medicarereimbursement, compliance, intellectual property, global market opportunities,corporate finance, public policy, emerging company issues, 21st century healthcare and the value of medical technology.

Whether you need to finance, partner or license technology, AdvaMed 2007introduces you to key decision-makers featuring a business developmentpartnering program, company presentations, and an exhibition showcasing thelatest medical technologies and products. Attendees will have the opportunityto directly access key players, inform stakeholders as to the progress of ourindustry, and influence the business, political and financial climates soimperative to innovation.

For more information, visit http://www.AdvaMed2007.com or call(202) 434-7213.The first round of companies selected to present at AdvaMed 2007 are: -- Advanced Liquid Logic of Research Triangle Park, North Carolina. (http://www.liquid-logic.com) -- Alcon of Fort Worth, Texas. (http://www.alcon.com) -- Axial Biotech of Salt Lake City, Utah. (http://www.axialbiotech.com) -- CarioMag Imaging of Sch


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement
Advertisement

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook